Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Daiichi Sankyo Co., Ltd.
Condition: Colorectal Neoplasm
NCT03384940
DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.